Arena Pharmaceuticals, Inc. Debt to Equity Ratio 2010-2021 | ARNA
Current and historical debt to equity ratio values for Arena Pharmaceuticals, Inc. (ARNA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Arena Pharmaceuticals, Inc. debt/equity for the three months ending December 31, 2021 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2021-12-31 | $0.11B | $0.67B | 0.17 |
| 2021-09-30 | $0.10B | $0.80B | 0.13 |
| 2021-06-30 | $0.11B | $0.97B | 0.12 |
| 2021-03-31 | $0.10B | $1.09B | 0.09 |
| 2020-12-31 | $0.11B | $1.08B | 0.10 |
| 2020-09-30 | $0.11B | $1.17B | 0.09 |
| 2020-06-30 | $0.10B | $1.24B | 0.08 |
| 2020-03-31 | $0.10B | $0.99B | 0.10 |
| 2019-12-31 | $0.10B | $1.07B | 0.10 |
| 2019-09-30 | $0.10B | $1.15B | 0.08 |
| 2019-06-30 | $0.08B | $1.20B | 0.07 |
| 2019-03-31 | $0.09B | $1.24B | 0.07 |
| 2018-12-31 | $0.08B | $0.61B | 0.13 |
| 2018-09-30 | $0.08B | $0.53B | 0.15 |
| 2018-06-30 | $0.08B | $0.56B | 0.14 |
| 2018-03-31 | $0.10B | $0.58B | 0.17 |
| 2017-12-31 | $0.13B | $0.21B | 0.64 |
| 2017-09-30 | $0.13B | $0.22B | 0.60 |
| 2017-06-30 | $0.11B | $0.08B | 1.30 |
| 2017-03-31 | $0.11B | $0.03B | 4.24 |
| 2016-12-31 | $0.13B | $0.04B | 3.18 |
| 2016-09-30 | $0.21B | $0.00B | 50.57 |
| 2016-06-30 | $0.20B | $0.01B | 15.07 |
| 2016-03-31 | $0.20B | $0.04B | 5.43 |
| 2015-12-31 | $0.20B | $0.05B | 3.80 |
| 2015-09-30 | $0.20B | $0.08B | 2.48 |
| 2015-06-30 | $0.22B | $0.11B | 2.07 |
| 2015-03-31 | $0.23B | $0.13B | 1.81 |
| 2014-12-31 | $0.23B | $0.05B | 4.84 |
| 2014-09-30 | $0.22B | $0.08B | 2.89 |
| 2014-06-30 | $0.23B | $0.10B | 2.25 |
| 2014-03-31 | $0.24B | $0.13B | 1.92 |
| 2013-12-31 | $0.25B | $0.09B | 2.70 |
| 2013-09-30 | $0.18B | $0.11B | 1.63 |
| 2013-06-30 | $0.15B | $0.13B | 1.23 |
| 2013-03-31 | $0.16B | $0.08B | 1.94 |
| 2012-12-31 | $0.16B | $0.10B | 1.65 |
| 2012-09-30 | $0.15B | $0.12B | 1.25 |
| 2012-06-30 | $0.15B | $0.11B | 1.40 |
| 2012-03-31 | $0.14B | $0.05B | 3.19 |
| 2011-12-31 | $0.15B | $0.01B | 13.88 |
| 2011-09-30 | $0.15B | $0.04B | 4.27 |
| 2011-06-30 | $0.15B | $0.06B | 2.49 |
| 2011-03-31 | $0.16B | $0.08B | 1.99 |
| 2010-12-31 | $0.19B | $0.08B | 2.33 |
| 2010-09-30 | $0.19B | $0.11B | 1.77 |
| 2010-06-30 | $0.16B | $0.08B | 2.02 |
| 2010-03-31 | $0.16B | $0.07B | 2.31 |
| 2009-12-31 | $0.16B | $0.08B | 2.17 |
| 2009-09-30 | $0.17B | $0.10B | 1.61 |
| 2009-06-30 | $0.12B | $0.05B | 2.64 |
| 2009-03-31 | $0.13B | $0.07B | 2.01 |
